TSE:4373 stock news
This page provides real-time market news, earnings updates, and company announcements related to Simplex Holdings,Inc. (TSE:4373).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-21 24:57 JST
Ethereum Updates Today: Buterin Moves ETH to Safeguard Privacy Against Major Financial Players and Quantum Threats
Bitget-RWA2025-11-27 14:38:34
Ethereum Updates Today: Privacy First: Buterin Backs Messaging’s Fundamental Transformation
Bitget-RWA2025-11-28 05:47:55
Ethereum Updates Today: Vitalik Buterin: Privacy Should Be Considered Digital Hygiene, Not an Exclusive Privilege
Bitget-RWA2025-11-29 00:50:27
MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Finviz2026-02-12 13:36:12
Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack Kits
Finviz2026-02-17 12:03:44
Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-02-17 12:03:44
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
Finviz2026-02-19 21:04:00
Candel Therapeutics Announces Proposed $100 Million Public Offering
Finviz2026-02-19 21:09:44
Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston
Finviz2026-02-24 13:06:43
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-02 21:09:42
Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting
Finviz2026-03-09 12:09:54
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:09:10
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
Finviz2026-03-17 12:09:49
Hologic's Women's Health Index Highlights Concerning Shortfalls in STI Testing
101 finance2026-03-19 14:19:03
Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack Kits
Finviz2026-02-17 12:03:44
Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-02-17 12:03:44
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
Finviz2026-02-19 21:04:00
Candel Therapeutics Announces Proposed $100 Million Public Offering
Finviz2026-02-19 21:09:44
Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston
Finviz2026-02-24 13:06:43
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-02 21:09:42
Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting
Finviz2026-03-09 12:09:54
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:09:10
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
Finviz2026-03-17 12:09:49
Hologic's Women's Health Index Highlights Concerning Shortfalls in STI Testing
101 finance2026-03-19 14:19:03
TSE:4373 stock price change
On the last trading day, TSE:4373 stock closed at 846.00 JPY, with a price change of 2.05% for the day.
Trade stock perpsTSE:4373 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more